News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.


Geopolitical Tensions Curb Crypto Optimism as Bitcoin and XRP Face Cautious Outlook
Cointurk·2026/02/18 17:51

Goldman CEO, NYSE President Attend Trump-Backed World Liberty Crypto Event
Finviz·2026/02/18 17:42

SocGen's FORGE expands euro stablecoin to XRP Ledger in multi-chain push
Cointelegraph·2026/02/18 17:42
What's Going On With Arm Holdings Stock?
Finviz·2026/02/18 17:39

Why Shopify (SHOP) Stock Is Up Today
Finviz·2026/02/18 17:39

Is Chegg's $40B Skilling Market Bet a True Turnaround Catalyst?
Finviz·2026/02/18 17:39

FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
Finviz·2026/02/18 17:39

Invesco Gains 16.6% in 3 Months: How to Play the Stock Now
Finviz·2026/02/18 17:33
Analog Devices Stock Hits 52-Week High Thanks To Data Center Demand
Finviz·2026/02/18 17:30
Prediction Markets Revolutionize Traditional Finance: NYSE President Reveals Stunning Integration
Bitcoinworld·2026/02/18 17:30
Flash
11:03
Micron, Samsung, and SK Hynix Face Class-Action Lawsuit in the United States, Accused of Violating Antitrust LawBlockBeats News, June 29th – Last Friday, the Northern District of California Federal Court received a class-action lawsuit against Samsung Electronics, SK Hynix, and Micron Technology. The plaintiffs, including consumers and small businesses, accuse the three companies of violating antitrust laws by coordinating to restrict traditional DRAM production capacity, artificially creating shortages and raising prices.
According to the complaint, the aforementioned collusion has led to a cumulative 700% increase in commercial DRAM prices over the past four years, causing widespread impact on global consumer electronics and business IT procurement. Apple's recent widespread price increases for the iPad and Mac have been cited by the plaintiffs as a typical case of price transmission: the supply gap manufactured by the three firms upstream has been cascaded through the industry chain and ultimately borne by end consumers.
10:59
According to a filing submitted to the U.S. Securities and Exchange Commission, Atlas Lithium Corporation has obtained the relevant authorization to operate a lithium processing plant and sell lithium concentrate products.This development marks a critical step for the company in its lithium resource development project, establishing a legal and operational foundation for subsequent production and commercial activities.
10:59
UnitedHealthcare announced that its Lungfx™ device has received approval from the U.S. Food and Drug Administration for use in centralized ex vivo lung perfusion procedures.This regulatory milestone marks a significant advancement for the company in organ care technology. It is expected to improve the efficiency of donor lung evaluation, repair, and utilization, bringing hope to more patients awaiting lung transplants.
News